AlphaThera News & Updates

Track our progress, grant history, and new developments.
3 Results
Partnerships
12/09/2021
Expansion of AlphaThera’s Distributor Network supports worldwide delivery of oYo-Link Antibody Labeling Technology

AlphaThera has announced the further expansion of its distributor network as interest in their oYo-Link Site Specific Antibody Labeling Technology continues to grow on an international scale.

Read more
Partnerships
10/15/2021
oYo-Link® Products Now Available to Purchase through Quartzy

AlphaThera has teamed up with Quartzy to make their oYo-Link Antibody labeling products conveniently available to researchers for purchase.

Read more
Partnerships
09/09/2021
Funakoshi Co., Ltd. Announced as AlphaThera’s Distribution Partner in Japan

AlphaThera has announced a distribution agreement with Funakoshi Co., Ltd. to deliver oYo-Link® Antibody labeling products to researchers in Japan.

Read more
4 Results
Product Launch
04/13/2023
AlphaThera announces the launch of oYo-Capture™ Magnetic Beads

For the efficient removal of free oYo-Link® post conjugation AlphaThera has announced the launch of oYo-Capture™ Magnetic Beads, providing researchers with an efficient method of removing free oYo-Link® reagents post antibody conjugation to ensure low background in high sensitivity assays. AlphaThera is well known within the life science research community for their oYo-Link® antibody labeling […]

Read more
Product Launch
01/30/2023
AlphaThera launches oYo-Link® Horseradish Peroxidase (HRP)

AlphaThera has announced the launch of oYo-Link® Horseradish Peroxidase (HRP), the latest addition to their range of site-specific antibody labeling reagents. The oYo-Link antibody-HRP labeling technology will enable the rapid production of highly uniform primary antibody conjugates in under two hours, and with only 30 seconds hands-on time.

Read more
Product Launch
06/20/2022
AlphaThera Expand Their Range of oYo-Link Antibody-Drug Conjugate Reagents

AlphaThera have announced the addition of DM4 to their range of oYo-Link® Antibody-Drug Conjugation Reagents which also includes VcMMAE, VcMMAF and DM1.

Read more
Product Launch
04/20/2020
AlphaThera Launches oYo-Link® Epitope Tag for Enhanced Multiplexing Capability

AlphaThera has announced the launch of oYo-Link® Epitope Tag, the latest addition to their range of site-specific antibody labeling reagents.

Read more
4 Results
Publication
02/07/2022
AlphaThera Highlighted in Nature Methods Article: “How single-cell multi-omics builds relationships”

Dr. Andrew Tsourkas and Dr. Feifan Yu interview about oYo-Link Oligo technology and its potential within the field of multi-omic single-cell analysis.

Read more
Publication
05/24/2021
AlphaThera & Penn Researchers’ Publication: Efficient native IgG labeling for ADC Production

AlphaThera members & Penn researchers worked to publish a high-impact publication in Bioconjugate Chemistry titled “Efficient Labeling of Native Human IgG by Proximity-Based Sortase-Mediated Isopeptide Ligation”.

Read more
Publication
01/13/2021
Publication Feature: “Targeting cartilage EGFR pathway for osteoarthritis treatment” Science Translational Medicine

Read how a research team used AlphaThera’s site-specific bioconjugation technique to seed nanoparticles with a TGFa payload.

Read more
Publication
10/07/2020
AlphaThera in the News: Atlas of Science

A layman’s summary of AlphaThera’s LASIC site-specific Antibody labeling technology was published by the Atlas of Science.

Read more